| #42 |
Hans Peter Grimm |
Hoffmann-La Roche |
1 |
| #42 |
Adrian Britschgi |
C4 Therapeutics |
1 |
| #42 |
Zorica DRAGIC |
Novartis Ag |
1 |
| #42 |
Joerg Kallen |
Novartis Ag |
1 |
| #42 |
Marta Cosenza |
Novartis Ag |
1 |
| #42 |
Jonas Fast |
Hoffmann-La Roche |
1 |
| #42 |
Anja Sarah Paulus |
Hoffmann-La Roche |
1 |
| #42 |
Tobias SCHMELZLE |
Novartis Ag |
1 |
| #42 |
Mehdi Heydari |
Paul Scherrer Institut |
1 |
| #42 |
Berend Frenzel |
— |
1 |
| #42 |
Andre Fuchs |
Ciba Specialty Chemicals |
1 |
| #42 |
Jonas Dahl |
Adobe |
1 |
| #42 |
Felipe José Oliveira Varum |
Tillotts Pharma Ag |
1 |
| #42 |
Kai Urban |
Dsm Ip Assets B.V. |
1 |
| #42 |
Masato Hoshino |
Nissan Motor Co. |
1 |
| #42 |
Sabine Sewing |
Hoffmann-La Roche |
1 |
| #42 |
Thomas Pfohl |
University Of Basel |
1 |
| #42 |
Tobias Nilsson |
Hoffmann-La Roche |
1 |
| #42 |
Daniel Turley |
Hoffmann-La Roche |
1 |
| #42 |
Elena GROSS |
— |
1 |
| #42 |
Julia Annette Carli |
— |
1 |
| #42 |
Georg Wuitschik |
Hoffmann-La Roche |
1 |
| #42 |
Rudolf Walchli |
Novartis Ag |
1 |
| #42 |
Stephan Mestan |
— |
1 |
| #42 |
Jorge Rosado |
— |
1 |
| #42 |
Daniel Hunziker |
Basilea Pharmaceutica Ag |
1 |
| #42 |
Thomas Odrich |
— |
1 |
| #42 |
Kurt Puentener |
Hoffmann-La Roche |
1 |
| #42 |
Alexander Alanine |
Hoffmann-La Roche |
1 |
| #42 |
Simon Breitler |
Hoffmann-La Roche |
1 |
| #42 |
Dragana Jankovic |
Universitat Zurich |
1 |
| #42 |
Thorben Hammerich |
Hoffmann-La Roche |
1 |
| #42 |
Alain Duerr |
Fisher Clinical Services Gmbh |
1 |
| #42 |
Sergio Lociuro |
Bioversys Ag |
1 |
| #42 |
Judith Flock |
Medos International Sarl |
1 |
| #42 |
Ekaterina V. Breous-Nystrom |
Agenus |
1 |
| #42 |
Bindhumadhavan Gururajan |
Novartis Ag |
1 |